Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current insulin infusion set failure criteria may be too stringent for real-life settings and may skew infusion set failure outcomes in extended-wear infusion set studies.
Kastner JR, Poettler T, Kopanz J, Hochfellner DA, Romey M, Baumann PM, Muchmore D, Strasma PJ, Mader JK. Kastner JR, et al. Among authors: mader jk. Diabetes Obes Metab. 2023 Apr;25(4):1106-1111. doi: 10.1111/dom.14935. Epub 2022 Dec 23. Diabetes Obes Metab. 2023. PMID: 36482830 No abstract available.
Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes.
Ruan Y, Thabit H, Leelarathna L, Hartnell S, Wilinska ME, Tauschmann M, Dellweg S, Benesch C, Mader JK, Holzer M, Kojzar H, Evans ML, Pieber TR, Arnolds S, Hovorka R; AP@home consortium. Ruan Y, et al. Among authors: mader jk. Diabetes Obes Metab. 2017 Oct;19(10):1485-1489. doi: 10.1111/dom.12956. Epub 2017 Jun 23. Diabetes Obes Metab. 2017. PMID: 28371223 Free PMC article. Clinical Trial.
Hypoglycaemia incidence and recovery during home use of hybrid closed-loop insulin delivery in adults with type 1 diabetes.
Ruan Y, Bally L, Thabit H, Leelarathna L, Hartnell S, Tauschmann M, Wilinska ME, Evans ML, Mader JK, Kojzar H, Dellweg S, Benesch C, Arnolds S, Pieber TR, Hovorka R. Ruan Y, et al. Among authors: mader jk. Diabetes Obes Metab. 2018 Aug;20(8):2004-2008. doi: 10.1111/dom.13304. Epub 2018 Apr 16. Diabetes Obes Metab. 2018. PMID: 29577536 Free PMC article. Clinical Trial.
Short-term effects of dapagliflozin on insulin sensitivity, postprandial glucose excursion and ketogenesis in type 1 diabetes mellitus: A randomized, placebo-controlled, double blind, cross-over pilot study.
Melmer A, Kempf P, Lunger L, Pieber TR, Mader JK, Stettler C, Tilg H, Ebenbichler CF, Laimer M. Melmer A, et al. Among authors: mader jk. Diabetes Obes Metab. 2018 Nov;20(11):2685-2689. doi: 10.1111/dom.13439. Epub 2018 Jul 12. Diabetes Obes Metab. 2018. PMID: 29923299 Clinical Trial.
GlucoTab-guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes.
Aberer F, Lichtenegger KM, Smajic E, Donsa K, Malle O, Samonigg J, Höll B, Beck P, Pieber TR, Plank J, Mader JK. Aberer F, et al. Among authors: mader jk. Diabetes Obes Metab. 2019 Mar;21(3):584-591. doi: 10.1111/dom.13559. Epub 2018 Nov 11. Diabetes Obes Metab. 2019. PMID: 30328252 Free PMC article. Clinical Trial.
A head-to-head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot.
Moser O, Pandis M, Aberer F, Kojzar H, Hochfellner D, Elsayed H, Motschnig M, Augustin T, Kreuzer P, Pieber TR, Sourij H, Mader JK. Moser O, et al. Among authors: mader jk. Diabetes Obes Metab. 2019 Apr;21(4):1043-1048. doi: 10.1111/dom.13598. Epub 2018 Dec 25. Diabetes Obes Metab. 2019. PMID: 30484947 Free PMC article.
155 results